Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Danielle Candelieri"'
Autor:
Lova Sun, Danielle Candelieri-Surette, Tori Anglin-Foote, Julie A. Lynch, Kara N. Maxwell, Christopher D’Avella, Aditi Singh, Erin Aakhus, Roger B. Cohen, Robert M. Brody
Publikováno v:
JAMA otolaryngology-- headneck surgery. 148(11)
ImportanceCetuximab-based and carboplatin-based chemoradiotherapy (CRT) are often used for patients with locally advanced head and neck cancer who are ineligible for cisplatin. There are no prospective head-to-head data comparing cetuximab-based and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365de132ef018e5c34fd9918eddb5a9b
https://pubmed.ncbi.nlm.nih.gov/36136306
https://pubmed.ncbi.nlm.nih.gov/36136306
Autor:
Anna Hung, Danielle Candelieri, Yanhong Li, Patrick Alba, Brian Robison, Fatai Agiri, Cristina Perez, Kyung-Min Lee, Kara N. Maxwell, Weiyan Li, Himani Aggarwal, Kathryn Pridgen, Shelby D. Reed, Scott DuVall, Yu-Ning Wong, Julie A. Lynch
Publikováno v:
Seminars in Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e13c08cda702f97cc6da81b4f7018ef
https://doi.org/10.1053/j.seminoncol.2023.03.001
https://doi.org/10.1053/j.seminoncol.2023.03.001
Autor:
Lova Sun, Robert Brody, Danielle Candelieri, Tori Anglin-Foote, Julie Ann Lynch, Ryan Hausler, Kara Noelle Maxwell, Scott Damrauer, Eric Ojerholm, John Nicholas Lukens, Roger B. Cohen, Kelly D. Getz, Rebecca A. Hubbard, Bonnie Ky
Publikováno v:
Journal of Clinical Oncology. 40:6057-6057
6057 Background: Cardiovascular disease and stroke are important causes of long-term morbidity and mortality in patients with oropharyngeal squamous cell carcinoma (OPSCC). Cancer treatments including radiotherapy to the neck and chemotherapy have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cae827a9b75ff1b2de08894c24141c6e
https://doi.org/10.1200/jco.2022.40.16_suppl.6057
https://doi.org/10.1200/jco.2022.40.16_suppl.6057
Autor:
Anna Hung, Yanhong Li, Danielle Candelieri, Patrick Alba, Tori Anglin-Foote, Kyung Min Lee, Fatai Agiri, Cristina Perez, Weiyan Li, Suvina Amin, Shan Jiang, Scott L. DuVall, Yu-Ning Wong, Shelby D. Reed, Julie Ann Lynch
Publikováno v:
Journal of Clinical Oncology. 40:47-47
47 Background: Practice guidelines have been modified to recommend hereditary and tumor gene mutation testing in patients with metastatic castration-resistant prostate cancer (mCRPC) to identify patients for molecularly targeted therapies. Identifyin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f09c7eb497e28975fdc64f303fe9d58
https://doi.org/10.1200/jco.2022.40.6_suppl.047
https://doi.org/10.1200/jco.2022.40.6_suppl.047